Macarthur.

Trial name or title	"Efficacy of intermittent sulfadoxine‐pyrimethamine and sulfadoxine‐pyrimethamine + artesunate treatment in the prevention of malaria in pregnancy in an area with chloroquine‐resistant plasmodium falciparum"
Methods
Participants	Expected enrolment: sample size not given Minimum age: 15 Inclusion criteria: HIV (?) pregnant women aged 15 years or older in their 1st or 2nd pregnancy Exclusion criteria: multigravida women, gestation age < 16 weeks or > 36 weeks, prior history of allergic reactions to sulfadoxine‐pyrimethamine or artesunate
Interventions	1. Intervention: sulfadoxine‐pyrimethamine plus artesunate 2. Control: sulfadoxine‐pyrimethamine
Outcomes	1. Placental parasitaemia 2. Adverse reactions. 3. Parasitemia at delivery 4. Maternal illness 5. Birth weight 6. Gestational age
Starting date	January 2003
Contact information	John Macarthur Tel: 770‐488‐7755 ZAE5@CDC.GOV
Notes	ClinicalTrials.gov identifier: NCT00164255 Study finished and data analysis going on